Mortality of patients with critical bleeding requiring massive transfusion is high. Although hypothermia, acidosis and coagulopathy have been well described as important determinants of mortality in patients with critical bleeding requiring massive transfusion, the risk factors and outcome associated with hypocalcaemia in these patients remain uncertain. This cohort study assessed the relationship between the lowest ionised calcium concentration during the 24-hour period of critical bleeding and the hospital mortality of 352 consecutive patients, while adjusting for diagnosis, acidosis, coagulation results, transfusion requirements and use of recombinant factor VIIa. Hypocalcaemia was common (mean concentrations 0.77 mmol/l, SD 0.19) and had a linear, concentrationdependent relationship with mortality (odds ratio [OR] 1.25 per 0.1 mmol/l decrement, 95% confidence interval [CI]: 1.04 to 1.52; P=0.02). Hypocalcaemia accounted for 12.5% of the variability and was more important than the lowest fibrinogen concentrations (10.8%), acidosis (7.9%) and lowest platelet counts (7.7%) in predicting hospital mortality. The amount of fresh frozen plasma transfused (OR 1.09 per unit, 95% CI: 1.02 to 1.17; P=0.02) and acidosis (OR 1.45 per 0.1 decrement, 95% CI: 1.19 to 1.72; P=0.01) were associated with the occurrence of severe hypocalcaemia (<0.8 mmol/l). In conclusion, ionised calcium concentrations had an inverse concentration-dependent relationship with mortality of patients with critical bleeding requiring massive transfusion. Both acidosis and the amount of fresh frozen plasma transfused were the main risk factors for severe hypocalcaemia. Further research is needed to determine whether preventing ionised hypocalcaemia can reduce mortality of patients with critical bleeding requiring massive transfusion.
Critical bleeding requiring massive transfusion is associated with significant mortality and morbidity 1 . Many complications of massive transfusion and critical bleeding are inter-related and may perpetuate one another. It is clear that preventing the 'vicious cycle' of coagulopathy, hypothermia and acidosis is pivotal in the survival of patients with critical bleeding requiring massive transfusion [1] [2] [3] .
Calcium is an important cation in the body and has a fundamental role as a co-factor in enzymatic reactions, transmembrane ion flux, muscle contraction, neuronal activity, coagulation cascade, platelet aggregation, regulation of vasomotor tone and cardiac contractility 4, 5 . Hypocalcaemia may occur in patients with critical bleeding requiring massive transfusion, leading to worsening coagulopathy 6, 7 and prolonged QT interval and ventricular arrhythmias in the presence of co-existing hypomagnesaemia 8 . The minimum acceptable ionised calcium concentration during critical bleeding remains controversial and uncertain. Although an in vitro study demonstrated that ionised calcium concentrations >0.56 mmol/l would be adequate for clot formation 9 , clinical studies indicate that ionised calcium concentrations <0.90 mmol/l during critical bleeding are associated with worse outcomes, although it is not clear that this is through an effect on coagulation 2 . Citrate toxicity has been suggested as the mechanism of hypocalcaemia during massive transfusion 6, 10 . However, recent evidence suggests that intravenous colloid solutions and ischaemiareperfusion can also cause hypocalcaemia and exacerbate hypocalcaemia-induced coagulopathy 11, 12 .
We hypothesised that hypocalcaemia is common and may have a concentration-dependent relationship with mortality in patients with critical bleeding requiring massive transfusion, and conducted a cohort study to assess the outcome and risk factors associated with hypocalcaemia in massive transfusion.
MATERIALS AND METHODS
This cohort study utilised the clinical, laboratory and mortality data of patients with critical bleeding requiring massive transfusion between 2002 and 2008 at Royal Perth Hospital. Royal Perth Hospital is Western Australia's designated major trauma and cardiothoracic centre and admits adult patients after major trauma including burns, and patients for heart-lung transplantation. In this study, massive transfusion was defined as transfusion of ≥10 units of allogeneic packed red blood cells or whole blood within a 24-hour period. A transfusion protocol, developed by a group of haematologists, transfusion specialists, surgeons, intensive care specialists and anaesthetists, was used in the study hospital during the study period. In this protocol, maintaining ionised calcium concentrations above 1.12 mmol/l during the period of critical bleeding was recommended.
Prospectively collected data of consecutive patients requiring massive transfusion from the transfusion service, laboratory and intensive care unit databases were linked. An investigator (KMH) who was not involved in the prospective collection of data, crosschecked the accuracy of all data after the data were linked. Because of the observational nature of the study, informed consent from patients was waived and this study was registered as a clinical audit in the clinical safety and quality unit of the hospital.
The outcomes of interest were hospital mortality and risk factors associated with occurrence of hypocalcaemia. Data analysed included age, gender, ABO blood group, diagnosis, Acute Physiology and Chronic Health Evaluation (APACHE) II score, the total amount and specific components of the massive transfusion, the worst laboratory data including acidosis, ionised calcium concentrations and coagulation profile during the 24-hour period of massive transfusion, a technique very similar to the APACHE prognostic model. In patients who had more than one episode of massive transfusion during the study period, only data related to the first episode of the massive transfusion were analysed. Data on the incidence of hypomagnesaemia and the lack of interactions between hypomagnesaemia and hypocalcaemia in massive transfusion were reported in our previous study 13 .
Statistical analyses
Continuous variables with a near normal distribution were analysed by t-test, and categorical or continuous variables with skewed distributions were analysed by chi-square and Mann-Whitney U tests, respectively. Multivariate logistic regression analysis was used to assess the association between lowest ionised calcium concentrations and hospital mortality. In this multivariate analysis, the relationship between lowest ionised calcium concentrations and mortality was progressively adjusted for by other confounders and covariates, in a step-by-step fashion. The confounders analysed included age, diagnosis, APACHE II score, the total number of units of allogeneic red blood packed cells, fresh frozen plasma, platelets or cryoprecipitate, acidosis, lowest platelet counts, worst coagulation profile (international normalisation ratio, activated partial thromboplastin time, fibrinogen concentrations) and use of recombinant factor VIIa, within the 24-hour period of critical bleeding.
The potential non-linear relationship between ionised calcium concentrations and mortality were assessed by a 4-knot restricted cubic spline function, which is similar to a polynomial function, while adjusting for all other covariates in the final multivariate model 14, 15 . The contribution of lowest ionised calcium concentrations, modelled as a continuous covariate, in explaining the variability of hospital mortality was calculated using the proportion of chi-square contribution by the lowest ionised calcium concentrations relative to the total chisquare contribution of all covariates in the model 14, 15 . Finally, a sensitivity analysis by excluding patients who had critical bleeding after cardiothoracic surgery was conducted. Logistic regression was used to assess the risk factors for severe ionised hypocalcaemia (<0.8 mmol/l). All statistical tests were two-tailed, performed by SPSS (version 18.0, 2009, IL, USA) and S-plus (version 8.0, 2007, Insightful Corp., Seattle, Washington, USA) software, and P <0.05 was regarded as significant.
RESULTS
Of the 353 consecutive patients requiring massive transfusion included in the study, 352 patients (99.7%) had their ionised calcium concentrations measured during the 24-hour period of massive transfusion. The mean ionised calcium concentration of the cohort was well below normal limits (mean concentration=0.8, interquartile range=0.7 to 0.9) and severe hypocalcaemia (<0.8 mmol/l) was common (52%) (Table 1, Figure 1 ). Most of the Table 2 ). Restricting the final multivariate model to patients who had critical bleeding from causes other than cardiothoracic surgery also did not change the magnitude and direction of association between ionised calcium concentrations and mortality.
When modelled as a continuous covariate, ionised calcium concentrations accounted for about 12.5% (95% CI 9.4 to 16.4%) of the variability in determining hospital mortality and was more important than the lowest fibrinogen concentrations (10.8%, 95% CI 8.0 to 14.5%), acidosis (7.9%, 95% CI 5.6 to 11.3%) and lowest platelet counts (7.7%, 95% CI 5.3 to 10.9%) ( Figure 2) . The relationship between lowest ionised calcium concentrations and mortality was in an inverse and relatively linear fashion (Figure 3 ). 
DISCUSSION
Our results showed that hypocalcaemia was common in patients with critical bleeding requiring massive transfusion, and that the lowest ionised calcium concentrations during the 24-hour period of critical bleeding had an inverse concentrationdependent association with mortality. The amount of fresh frozen plasma transfused and acidosis were significant risk factors for the occurrence of severe hypocalcaemia.
There are a number of possible explanations for the association between lowest ionised hypocalcaemia and mortality in patients with critical bleeding requiring massive transfusion. First, calcium is an essential co-factor for vitamin K-dependent coagulation factors and platelet aggregation 5 .
Although an in-vitro study has demonstrated that hypocalcaemia may not be important for clot formation unless the ionised calcium concentrations were <0.56 mmol/l, this result may not be applicable to clinical situations where hypocalcaemia occurs in the context of co-existing acidosis, hypothermia and dilutional coagulopathy. Second, calcium has other important physiological functions including regulation of vasomotor tone and myocardial contractility. Animal studies showed that citrate infusion can induce ionised hypocalcaemia and reduce myocardial contractility 10 , and increasing ionised calcium concentrations from 0.9 to 1.1 mmol/l by intravenous calcium replacement in critically ill patients can significantly improve their haemodynamics within 30 minutes 4 . Third, hypocalcaemia may be a consequence, and not a modifiable cause of irreversible cellular dysfunction in dying patients. Intravenous colloid solutions and fresh frozen plasma may induce hypocalcaemia, and patients who need a large quantity of these fluids are also likely to be sicker and hence more likely to die from the critical bleeding. The lowest ionised calcium concentrations of our patients occurred mostly during the period of active resuscitation rather than at the time of death, suggesting that hypocalcaemia may not be just a marker of irretrievable cellular dysfunction near the time of death. Furthermore, the concentrationdependent relationship between hypocalcaemia and mortality also suggests that hypocalcaemia may have, at least in part, a direct adverse effect on mortality of patients with critical bleeding. Therefore, ionised hypocalcaemia may represent one of the important components of the 'vicious cycle' in patients with critical bleeding (Figure 4 ). Although the direct cause and effect relationship between hypocalcaemia and mortality is still not proven, it would be prudent to monitor ionised calcium concentrations and correct hypo-calcaemia in patients with critical bleeding requiring massive transfusion.
Our data suggest that acidosis and the amount of fresh frozen plasma transfused are two important risk factors for severe hypocalcaemia. It has been hypothesised that citrate toxicity is the major mechanism of hypocalcaemia in massive transfusion 6, 7 , and significant hypocalcaemia only occurs when more than one unit of whole blood is transfused within 5 to 10 minutes 10 . Most sodium citrate and citric acids in a unit of whole blood is pooled to the fresh frozen plasma (20 mmol/l) when whole blood is separated into packed red blood cells and fresh frozen plasma 16 ; it is therefore not surprising that the amount of fresh frozen plasma used is an important risk factor for the occurrence of severe hypocalcaemia in massive transfusion 7 .
The reasons behind the association between acidosis and severe hypocalcaemia remain uncertain and speculative. First, lactate acidosis is an important marker of tissue hypoperfusion and hyperchloraemic acidosis can occur after resuscitation with a large quantity of intravenous fluids 17 . Recent evidence suggests that hypocalcaemia can occur after a large quantity of intravenous colloid solutions and ischaemia-reperfusion injury 11, 12 . As such, the association between hypocalcaemia and acidosis can be, in part, explained by the use of a large quantity of intravenous fluid for resuscitation and tissue ischaemia in patients with critical bleeding and haemorrhagic shock. Second, metabolism of citrate and lactate by the liver may be significantly reduced in patients who have hypothermia and liver dysfunction during critical bleeding 18, 19 , resulting in an accumulation of citrate and lactate ions in the blood simultaneously. This study has limitations. First, an observational study is prone to unmeasured bias and confounding. Although we have adjusted for many confounders in our analyses, residual confounding is still possible 20 . The number of deaths (n=128) in our cohort limits the power of our analysis to a maximum of about 12 to 13 predictors 21 , and as such a type II error is possible when more than 12 predictors were included in the final multivariate model. Second, this is a single centre study limiting its general applicability. Finally, because the frequency of calcium concentration measurements during critical bleeding was not specified in the transfusion protocol, it is possible that the calcium concentrations analysed in this study may not be the lowest calcium concentrations during the 24-hour period of massive transfusion in some patients.
Although the sample size of this study is still relatively small, to the best of our knowledge this is one of the largest studies specifically assessing the incidence, risk factors and outcome associated with hypocalcaemia in patients with critical bleeding requiring massive transfusion. We have also included many important confounders, such as severity of illness, diagnosis, acidosis, the worst coagulation profile, use of recombinant factor VIIa and potential non-linearity relationship between calcium concentrations and mortality in our analyses, making our results relatively robust.
In summary, hypocalcaemia was common in patients with critical bleeding requiring massive transfusion. Ionised calcium concentrations had an inverse concentration-dependent relationship with mortality in patients with critical bleeding requiring massive transfusion. Acidosis and the amount of fresh frozen plasma transfused were the main risk factors for severe hypocalcaemia. Further research is needed to determine whether preventing ionised hypocalcaemia can reduce mortality of patients with critical bleeding requiring massive transfusion.
